ALIPAY+
10.11.2021 08:15:11 CET | Business Wire | Press release
Whale Cloud , a leading technology company providing software solutions and services for telecommunications and multiple other industries, today reached a partnership with Toka Fintech , a Mexican-leading financial group, to help it develop its own digital payment app with Alipay+ Digital Wallet Solution, providing Mexicans with better access to inclusive financial services.
Toka Fintech is a company belonging to Grupo Toka, which is one of the most important groups in the prepaid card market and has more than 4.5 million customers in Mexico. Grupo Toka is increasingly embracing digital payment services because of the fast adoption of smartphones in the country and the COVID-19 pandemic.
In this partnership, with proven payment technology, project delivery and operation experience from Whale Cloud and Ant Group in global markets, Toka Fintech will further embark on its digital payment journey and bring the inclusive, digitalized and personalized services to more businesses and customers in Mexico.
Whale Cloud and Ant Group will help Toka Fintech develop an all-in-one digital payment app tailored for Latin America market, providing comprehensive payment services powered by innovative technologies including financial-grade cloud native computing and AI-driven risk management.
“As a company that aims to continuously create value for customers, Toka Fintech is taking the lead in encouraging the use of innovative technologies in the delivery of financial services. The partnership with Ant Group and Whale Cloud is a milestone for us to advance financial inclusion,” said Hugo Villanueva, CEO and Owner of Toka Fintech.
“We’re excited to serve the digital payment journey of Toka Fintech,” said Cheng Guoming, General Manager of Alipay+ Global Partnership, Ant Group. “Together with Whale Cloud, we are willing to share our technical know-how and experiences to accelerate customers’ digital transformation and help underbanked communities across the world enjoy more inclusive services.”
“Toka Fintech will be the first in Latin America to adopt Alipay+ Digital Wallet Solution. Whale Cloud is so happy to turn Toka’s strategy into actions to reinforce its market position in advancing inclusive digital services”, said Ben Zhou, CEO International, Whale Cloud.
Alipay+ Digital Wallet Solution provides a full-suite of payment technologies and products to help customers develop their own e-wallet apps more efficiently, enable their users to top up, transfer, withdraw money and enjoy financial services directly from mobile devices, while allow merchants to accept these users' online and offline payments, and manage their own loyalty and promotion campaigns.
Whale Cloud and Ant Group have formed a strategic partnership since 2020 to provide customers across industries with financial technology consulting, solution designing and delivery, and operation services.
About Grupo Toka and Toka Fintech
Toka Internacional, S.A.P.I. de C.V. “Toka” is a Mexican Company active in the issue of payment solutions, through electronic wallets in order to provide food, fuel, restaurant, travel allowance, etc. voucher services. The company started providing call center services to financial institutions and in 2012 they launched their first pre-payment card, business that has grown rapidly and become one of the top 5 electronic wallet issuer companies in Mexico.
In 2019 Toka created “Toka Fintech” as a strategy for continuous growth and taking advantage of the opportunity created by the new Fintech law in Mexico to commercialize its products to a B2C open market.
About Whale Cloud
Whale Cloud Technology Co., Ltd ("Whale Cloud") is a leading technology company specializing in telecom software development and delivery, cloud computing, big data analytics, AI-enabled service operations, IoT, Fintech solutions and other professional services including planning and consulting. Founded in 2003, the company provides services to various market segments including telecom operators, governments, and enterprises around the world. Whale Cloud’s business scope extends from telecom markets to vertical industries. It has built its core competitiveness in communications software, operation services, cloud computing, big data analytics, AI, and Internet architecture.
About Alipay+
Alipay+ provides global cross-border mobile payments and marketing solutions that enable global e-wallets and merchant partners, especially small and medium-sized businesses, to better serve their users and customers.
Alipay+ is introduced by Ant Group, the owner and operator of Alipay. One of the world’s leading digital payment platforms, Alipay serves hundreds of millions of users by connecting them with merchants and partner financial institutions that offer inclusive financial services and digital daily life services.
View source version on businesswire.com: https://www.businesswire.com/news/home/20211109006725/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
BeOne Medicines Reports Sustained Survival Benefit with TEVIMBRA-ZIIHERA Combination in First-Line HER2+ Gastroesophageal Cancer23.10.2026 16:15:00 CEST | Press release
New data from HERIZON-GEA-01 Phase 3 trial show 36-month overall survival of nearly 40% with TEVIMBRA plus ZIIHERA and chemotherapy, and median OS reaching 27 monthsTEVIMBRA-containing arm was associated with a four-month longer median OS compared with ZIIHERA plus chemotherapy BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new survival results from the planned second interim analysis (IA2) and final formal analysis of the Phase 3 HERIZON-GEA-01 trial, further confirming the benefit of TEVIMBRA® (tislelizumab) plus ZIIHERA® (zanidatamab) and chemotherapy as first-line treatment for patients with HER2-positive locally advanced or metastatic gastroesophageal adenocarcinoma (GEA). The results will be presented today as a late-breaking abstract during a rapid oral session at the European Society for Medical Oncology (ESMO) Congress 2026 in Madrid, Spain (LBA79). Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne,
Lifezone Metals Confirms Advanced Negotiations with Orion CMC on Kabanga Nickel Project23.10.2026 16:10:00 CEST | Press release
Lifezone Metals Limited (NYSE: LZM) notes comments made today by Oskar Lewnowski, Founder and Group Chief Executive of Orion Resource Partners, in an interview with Bloomberg Television regarding the Company’s Kabanga Nickel Project in Tanzania. In response to inbound inquiries from media outlets and investors following the interview, the Company can confirm that negotiations with Orion Critical Mineral Consortium (Orion CMC) regarding a significant equity investment into the Kabanga Nickel Project are at an advanced stage. The Orion CMC is a global investment platform launched by Orion Resource Partners in partnership with the U.S. International Development Finance Corporation (DFC) and Abu Dhabi's sovereign investor ADQ. As previously announced, the Company has been running a competitive process, led by Standard Chartered Bank, to secure a strategic investment into the Kabanga Nickel Project. Social Media LinkedIn | X | YouTube About Lifezone Metals Lifezone Metals (NYSE: LZM) is com
inDrive and Pony.ai Announce Collaboration to Explore Autonomous Mobility in Kazakhstan Built on NVIDIA Hyperion23.10.2026 15:00:00 CEST | Press release
Collaboration will establish the roadmap for bringing Pony.ai robotaxis to Kazakhstan on the inDrive ride-hailing platform, leveraging the NVIDIA Hyperion and the NVIDIA Halos safety system. inDrive, the global mobility and delivery platform, today announced it has signed a memorandum of understanding (MOU) with NVIDIA and Pony.ai, a global leader in the large-scale commercialization of autonomous driving technology, to explore the future of autonomous ride-hailing. Kazakhstan will serve as the first test market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261023143469/en/ inDrive partners with Pony.ai and NVIDIA to explore autonomous mobility in Kazakhstan Kazakhstan was chosen first for its regulatory readiness following the creation of the country’s first structured legal framework for driverless transport, as part of its “Year of Digitalization and Artificial Intelligence.” Combined with Kazakhstan’s position as a lea
Brenus Pharma's Novel In Vivo Immunotherapy STC-1010 Shows Safety, Activating T Cells in First-Line MSS Metastatic Colorectal Cancers With 2 Complete Responses.23.10.2026 14:50:00 CEST | Press release
Phase Ia BreAK CRC-001 at ESMO 2026: 43% of patients, all initially unresectable, became eligible for surgery Poster 1023P – Developmental Therapeutics Brenus Pharma, a clinical-stage biotech company, announced first data from the Phase Ia dose escalation of BreAK CRC-001. Nine unresectable patients were treated; 89% had liver metastases and 89% KRAS-mutant tumors, a population refractory to immunotherapy. Median follow-up: 8 months (1–14; data cut-off 6/08/2026). 95% of metastatic colorectal cancers are pMMR/MSS tumors, poorly immunogenic and resistant to immunotherapy. STC-1010, the company’s lead in vivo DC-engager, is designed to make these “cold” tumors visible to immune cells. Safety: no dose-limiting toxicity, only grade 1–2 related adverse events. Clinical activity (seven evaluable patients, RECIST 1.1): 100% disease control, 57% objective response rate (4/7). 43% of patients became operable (3/7): two with no evidence of disease afterward. Molecular profile: ctDNA dropped by u
Takeda Announces Arcotatug Tavatecan (TAK-921) Demonstrated Statistically Significant and Clinically Meaningful Improvements in Overall Survival and Progression-Free Survival in Phase 3 Advanced Gastric Cancer Study23.10.2026 13:30:00 CEST | Press release
Data from the Registrational Phase 3 G-HOPE-001 Study of Arcotatug Tavatecan, a Novel, Potential Best-in-Class Claudin (CLDN)18.2 ADC, were Highlighted in a Late-Breaking Presentation at ESMO 2026Arcotatug Tavatecan Met Dual Primary Endpoints of Overall Survival and Progression-Free Survival, Showing Significant Improvements vs. Treatment of Physician’s Choice in Patients with Previously Treated CLDN18.2-Positive Advanced Gastric CancerFindings to Support Planned Regulatory Filing in Japan and Continued Global Development of Arcotatug Tavatecan in CLDN18.2-Positive Cancers Takeda(TSE:4502/NYSE:TAK)announced positive results from the Phase 3 G-HOPE-001 study (NCT06238843) of arcotatug tavatecan (TAK-921; Innovent R&D code: IBI343) in patients with Claudin (CLDN)18.2-positive, previously treated, advanced gastric or gastroesophageal junction adenocarcinoma (G/GEJA). Results from two prespecified interim analyses, which were shared in a late-breaking oral presentation at the 2026 European
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom